Unknown

Dataset Information

0

Selective ?2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury.


ABSTRACT: ?(2)-adrenoreceptor activation has been shown to protect cardiac myocytes from cell death. We hypothesized that acute ?(2)-adrenoreceptor stimulation, using arformoterol (ARF), would attenuate myocardial ischemia/reperfusion (R) injury via NO synthase activation and cause a subsequent increase in NO bioavailability.Male C57BL/6J and endothelial NO synthase (eNOS) knockout mice were subjected to 45 minutes of myocardial ischemia and 24 hours of R. ARF or vehicle was administered 5 minutes before R. Serum troponin-I was measured, and infarct size per area-at-risk was evaluated at 24 hours of R. Echocardiography was performed at baseline and 2 weeks after R. Myocardial cAMP, protein kinase A, eNOS/Akt phosphorylation status, and NO metabolite levels were assayed. ARF (1 µg/kg) reduced infarct size per area-at-risk by 53.1% (P<0.001 versus vehicle) and significantly reduced troponin-I levels (P<0.001 versus vehicle). Ejection fraction was significantly preserved in ARF-treated hearts compared with vehicle hearts at 2 weeks of R. Serum cAMP and nuclear protein kinase A C-? increased 5 and 15 minutes after ARF injection, respectively (P<0.01). ARF increased Akt phosphorylation at Thr(308) (P<0.001) and Ser(473) (P<0.01), and eNOS phosphorylation at Ser(1177) (P<0.01). ARF treatment increased heart nitrosothiol levels (P<0.001) at 15 min after injection. ARF failed to reduce infarct size in eNOS(-/-) mice.Our results indicate that ?(2)-adrenoreceptor stimulation activates cAMP, protein kinase A, Akt, and eNOS and augments NO bioavailability. Activation of this prosurvival signaling pathway attenuates myocardial cell death and preserves cardiac function after ischemia/reperfusion.

SUBMITTER: Bhushan S 

PROVIDER: S-EPMC3401356 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2014-01-01 | S-EPMC4254980 | BioStudies
| S-EPMC3586978 | BioStudies
2018-01-01 | S-EPMC5952436 | BioStudies
| S-EPMC4558339 | BioStudies
1000-01-01 | S-EPMC3170947 | BioStudies
| S-EPMC4005884 | BioStudies
2015-01-01 | S-EPMC4564588 | BioStudies
| S-EPMC6383062 | BioStudies
2018-01-01 | S-EPMC5725281 | BioStudies
| S-EPMC3355212 | BioStudies